QUANTUM X LABS INC. quarterly report, Q1 FY2009

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2009, for Zaxis International Inc. (Note: The request metadata listed "Quantum X Labs Inc.", but the filing text identifies the registrant as Zaxis International Inc.). The company is a shell entity with no present operations, having ceased its former biotechnology business in 2002 and emerged from bankruptcy in 2004. Its current plan of operation is to pursue a business combination or acquisition. As of March 31, 2009, the company had 1,073,126 shares of common stock outstanding.

Key Financial Metrics

MetricQ1 2009Q1 2008
Revenue$0$0
Net Loss$(13,759)$(11,527)
Loss Per Share (Basic/Diluted)$(0.01)$(0.01)
Cash and Cash Equivalents (End of Period)$729$143
Total Assets$729$117
Total Current Liabilities$103,855$91,655
Stockholders' Deficiency$(103,126)$(91,538)

Liquidity and Debt: The company has no debt in the traditional sense but holds significant current liabilities consisting of accounts payable ($4,500) and advances/accruals due to related parties ($99,355). Cash flow from operations was negative ($88), while financing activities provided $700 in advances from related parties.

Material Changes vs. Prior Period

  • Net Loss Increase: Net loss increased by approximately 19% year-over-year, driven by a rise in general and administrative expenses from $11,527 to $13,759.
  • Liability Growth: Total current liabilities increased by $12,200, primarily due to an increase in advances from related parties.
  • Cash Position: Cash on hand increased from $117 at the end of 2008 to $729 at the end of Q1 2009, funded entirely by related party advances.
  • Non-Cash Expenses: The company recorded $9,000 in fair value of services provided by related parties and $2,171 in expenses paid by the issuance of common stock.

Outlook, Risks, and Management Commentary

Management Commentary: Management believes current market uncertainty creates opportunities for acquisitions. The company intends to use its public status to identify and effect a business combination, potentially with financially unstable or early-stage companies. No specific target industry or business has been identified.

Risks and Contingencies:

  • Lack of Operations: The company has no revenue and relies entirely on related party funding to sustain operations.
  • Liquidity Risk: The company has limited resources and may be unable to raise necessary capital to complete a business combination.
  • Dilution: Future business combinations may require the issuance of a substantial number of restricted shares, causing significant dilution to existing shareholders.
  • Single Business Dependency: It is probable the company will effect only a single business combination, leaving it undiversified and dependent on the success of that single entity.

Investor Verification Checklist

  • Verify the identity of the registrant (Zaxis International Inc.) versus the metadata provided (Quantum X Labs Inc.).
  • Confirm the sustainability of operations given the $103,855 in liabilities against only $729 in assets.
  • Assess the terms and repayment status of the $99,355 in advances from related parties.
  • Monitor for any announcements regarding a specific target for a business combination, as none is currently identified.
  • Review the potential for significant dilution if the company issues equity to fund a future acquisition.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.